Patents by Inventor Therese M. Downey
Therese M. Downey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11135241Abstract: Compositions are described that contain treated chitosan, modified chitosan and/or modified and treated chitosan for use in formulations for skin, hair and nails, and in compositions and methods of reducing topical agent-induced skin irritation and inflammation.Type: GrantFiled: December 13, 2018Date of Patent: October 5, 2021Assignees: Alumend, LLC, Wavepharma, LLCInventors: Ronald E. Utecht, Therese M. Downey, Miri Seiberg, Stanley S. Shapiro, Jack V. Foster, Jr.
-
Patent number: 11123362Abstract: Compositions are described that contain treated chitosan, modified chitosan and/or modified and treated chitosan for use in formulations for skin, hair and nails, and in compositions and methods of reducing topical agent-induced skin irritation and inflammation.Type: GrantFiled: December 13, 2018Date of Patent: September 21, 2021Assignees: Alumend, LLC, Wavepharma, LLCInventors: Ronald E. Utecht, Therese M. Downey, Miri Seiberg, Stanley S. Shapiro, Jack V. Foster, Jr.
-
Publication number: 20190183921Abstract: Compositions are described that contain treated chitosan, modified chitosan and/or modified and treated chitosan for use in formulations for skin, hair and nails, and in compositions and methods of reducing topical agent-induced skin irritation and inflammation.Type: ApplicationFiled: December 13, 2018Publication date: June 20, 2019Applicants: Alumend, LLC, WAVEPHARMA, LLCInventors: Ronald E. Utecht, Therese M. Downey, Miri Seiberg, Stanley S. Shapiro, Jack V. Foster, JR.
-
Publication number: 20190125781Abstract: Compositions are described that contain treated chitosan, modified chitosan and/or modified and treated chitosan for use in formulations for skin, hair and nails, and in compositions and methods of reducing topical agent-induced skin irritation and inflammation.Type: ApplicationFiled: December 13, 2018Publication date: May 2, 2019Applicants: Alumend, LLC, WAVEPHARMA, LLCInventors: Ronald E. Utecht, Therese M. Downey, Miri Seiberg, Stanley S. Shapiro, Jack V. Foster, JR.
-
Patent number: 10258643Abstract: Compositions are described that contain treated chitosan, modified chitosan and/or modified and treated chitosan for use in formulations for skin, hair and nails, and in compositions and methods of reducing topical agent-induced skin irritation and inflammation.Type: GrantFiled: June 12, 2017Date of Patent: April 16, 2019Assignees: Alumend, LLC, Wavepharma, LLCInventors: Ronald E. Utecht, Therese M. Downey, Miri Seiberg, Stanley S. Shapiro, Jack V. Foster
-
Patent number: 10245283Abstract: Compositions are described that contain treated chitosan, modified chitosan and/or modified and treated chitosan for use in formulations for skin, hair and nails, and in compositions and methods of reducing topical agent-induced skin irritation and inflammation.Type: GrantFiled: December 4, 2017Date of Patent: April 2, 2019Assignees: ALUMEND, LLC, WAVEPHARMA, LLCInventors: Ronald E. Utecht, Therese M. Downey, Miri Seiberg, Stanley S. Shapiro, Jack V. Foster, Jr.
-
Publication number: 20180344859Abstract: Novel biomaterials are disclosed having unique properties that make it a useful material in adhesives, local drug delivery applications and as filler or bulking material. The biomaterials are strong, safe and easily used as a surgical adhesive. Treated chitosan, modified chitosan or modified and treated chitosan compositions are disclosed displaying strengths suitable for general surgical applications. The materials can be used as a drug delivery vehicle which allows for the localization of the delivered drug as well as a programmable tether which allows for the release of the drug on a timed basis or in response to a physiological state such as the release of proteolytic enzymes. The materials of this invention can also be modified and treated to optimize the retention of water, thereby serving as a useful filler or bulking material.Type: ApplicationFiled: February 5, 2018Publication date: December 6, 2018Applicant: Alumend, LLCInventors: Ronald E. Utecht, Kaia L. Kloster, Therese M. Downey, Barbara R. Haberer
-
Publication number: 20180344858Abstract: Novel biomaterials are disclosed having unique properties that make it a useful material in adhesives, local drug delivery applications and as filler or bulking material. The biomaterials are strong, safe and easily used as a surgical adhesive. Treated chitosan, modified chitosan or modified and treated chitosan compositions are disclosed displaying strengths suitable for general surgical applications. The materials can be used as a drug delivery vehicle which allows for the localization of the delivered drug as well as a programmable tether which allows for the release of the drug on a timed basis or in response to a physiological state such as the release of proteolytic enzymes. The materials of this invention can also be modified and treated to optimize the retention of water, thereby serving as a useful filler or bulking material.Type: ApplicationFiled: December 29, 2017Publication date: December 6, 2018Applicant: Alumend, LLCInventors: Ronald E. Utecht, Kaia L. Kloster, Therese M. Downey, Barbara R. Haberer
-
Publication number: 20180092940Abstract: Compositions are described that contain treated chitosan, modified chitosan and/or modified and treated chitosan for use in formulations for skin, hair and nails, and in compositions and methods of reducing topical agent-induced skin irritation and inflammation.Type: ApplicationFiled: December 4, 2017Publication date: April 5, 2018Applicants: Alumend, LLC, WavePharma, LLCInventors: Ronald E. Utecht, Therese M. Downey, Miri Seiberg, Stanley S. Shapiro, Jack V. Foster, JR.
-
Patent number: 9884121Abstract: Biomaterials are disclosed having unique properties that make it a useful material in adhesives, local drug delivery applications and as filler or bulking material. The biomaterials are strong, safe and easily used as a surgical adhesive. Treated chitosan, modified chitosan or modified and treated chitosan compositions are disclosed displaying strengths suitable for general surgical applications. The materials can be used as a drug delivery vehicle which allows for the localization of the delivered drug as well as a programmable tether which allows for the release of the drug on a timed basis or in response to a physiological state such as the release of proteolytic enzymes. The materials of this invention can also be modified and treated to optimize the retention of water, thereby serving as a useful filler or bulking material.Type: GrantFiled: December 22, 2015Date of Patent: February 6, 2018Assignee: Alumend, LLCInventors: Ronald E. Utecht, Kaia L. Kloster, Therese M. Downey, Barbara R. Haberer
-
Patent number: 9855337Abstract: Biomaterials are disclosed having unique properties that make it a useful material in adhesives, local drug delivery applications and as filler or bulking material. The biomaterials are strong, safe and easily used as a surgical adhesive. Treated chitosan, modified chitosan or modified and treated chitosan compositions are disclosed displaying strengths suitable for general surgical applications. The materials can be used as a drug delivery vehicle which allows for the localization of the delivered drug as well as a programmable tether which allows for the release of the drug on a timed basis or in response to a physiological state such as the release of proteolytic enzymes. The materials of this invention can also be modified and treated to optimize the retention of water, thereby serving as a useful filler or bulking material.Type: GrantFiled: January 31, 2008Date of Patent: January 2, 2018Assignee: Alumend, LLCInventors: Ronald E. Utecht, Kaia L. Kloster, Therese M. Downey, Barbara R. Haberer
-
Patent number: 9833469Abstract: Compositions are described that contain treated chitosan, modified chitosan and/or modified and treated chitosan for use in formulations for skin, hair and nails, and in compositions and methods of reducing topical agent-induced skin irritation and inflammation.Type: GrantFiled: December 21, 2016Date of Patent: December 5, 2017Assignees: Alumend, LLC, WavePharma, LLCInventors: Ronald E. Utecht, Therese M. Downey, Miri Seiberg, Stanley S. Shapiro
-
Publication number: 20170274009Abstract: Compositions are described that contain treated chitosan, modified chitosan and/or modified and treated chitosan for use in formulations for skin, hair and nails, and in compositions and methods of reducing topical agent-induced skin irritation and inflammation.Type: ApplicationFiled: June 12, 2017Publication date: September 28, 2017Applicant: Alumend, LLCInventors: Ronald E. Utecht, Therese M. Downey, Miri Seiberg, Stanley S. Shapiro, Jack V. Foster, JR.
-
Publication number: 20170182086Abstract: Compositions are described that contain treated chitosan, modified chitosan and/or modified and treated chitosan for use in formulations for skin, hair and nails, and in compositions and methods of reducing topical agent-induced skin irritation and inflammation.Type: ApplicationFiled: December 21, 2016Publication date: June 29, 2017Applicant: Alumend, LLCInventors: Ronald E. Utecht, Therese M. Downey
-
Publication number: 20160175449Abstract: Novel biomaterials are disclosed having unique properties that make it a useful material in adhesives, local drug delivery applications and as filler or bulking material. The biomaterials are strong, safe and easily used as a surgical adhesive. Treated chitosan, modified chitosan or modified and treated chitosan compositions are disclosed displaying strengths suitable for general surgical applications. The materials can be used as a drug delivery vehicle which allows for the localization of the delivered drug as well as a programmable tether which allows for the release of the drug on a timed basis or in response to a physiological state such as the release of proteolytic enzymes. The materials of this invention can also be modified and treated to optimize the retention of water, thereby serving as a useful filler or bulking material.Type: ApplicationFiled: December 22, 2015Publication date: June 23, 2016Applicant: Alumend, LLCInventors: Ronald E. Utecht, Kaia L. Kloster, Therese M. Downey, Barbara R. Haberer
-
Patent number: 8252771Abstract: A biomaterial is disclosed having unique properties that make it useful in ocular drug delivery applications, where the drugs selected from the group consisting of a prostaglandin, a prostamide, a non-steroidal anti-inflammatory drug (NSAID), and a corticosteroid, and mixtures, derivatives, salts and esters thereof.Type: GrantFiled: January 31, 2008Date of Patent: August 28, 2012Assignee: Allergan, Inc.Inventors: Ronald E. Utecht, Kaia L. Kloster, Therese M. Downey, Barbara R. Haberer, Patrick D. Youso, James N. Chang
-
Publication number: 20080207561Abstract: A novel biomaterial is disclosed having unique properties that make it useful in ocular drug delivery applications, where the drugs selected from the group consisting of a prostaglandin, a prostamide, a non-steroidal anti-inflammatory drug (NSAID), and a corticosteroid, and mixtures, derivatives, salts and esters thereof.Type: ApplicationFiled: January 31, 2008Publication date: August 28, 2008Inventors: Ronald E. Utecht, Kaia L. Kloster, Therese M. Downey, Barbara R. Haberer, Patrick D. Youso, James N. Chang
-
Publication number: 20080200948Abstract: Novel biomaterials are disclosed having unique properties that make it a useful material in adhesives, local drug delivery applications and as filler or bulking material. The biomaterials are strong, safe and easily used as a surgical adhesive. Treated chitosan, modified chitosan or modified and treated chitosan compositions are disclosed displaying strengths suitable for general surgical applications. The materials can be used as a drug delivery vehicle which allows for the localization of the delivered drug as well as a programmable tether which allows for the release of the drug on a timed basis or in response to a physiological state such as the release of proteolytic enzymes. The materials of this invention can also be modified and treated to optimize the retention of water, thereby serving as a useful filler or bulking material.Type: ApplicationFiled: January 31, 2008Publication date: August 21, 2008Applicant: PHOTOBIOMED CORPORATIONInventors: Ronald E. Utecht, Kaia L. Kloster, Therese M. Downey, Barbara R. Haberer
-
Patent number: 5737674Abstract: A vapor control system and an electrophotographic system having a vapor control system for reducing vapor emissions. A vapor collection mechanism collects at least some of the vaporized carrier which is then transmitted to a container having a vapor inlet and a vapor outlet containing a cooling liquid, the cooling liquid having a temperature less than the temperature of the vaporized carrier but greater than zero degrees Centigrade. A vapor inlet located at a point below the surface of the cooling liquid results in the vaporized liquid bubbling through the cooling liquid and being condensed therein. The cooling liquid is immiscible with water and, preferably is the carrier liquid. Mechanical resistance devices promote increased bubble residence time and smaller bubble size.Type: GrantFiled: November 20, 1995Date of Patent: April 7, 1998Assignee: Minnesota Mining and Manufacturing CompanyInventors: Jai Venkatesan, James A. Baker, Therese M. Downey, Russell A. Roiko, Kay F. Schilli